WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Filters
List of articles in category FDA
Title Published Date
FDA approves first treatment for a form of Batten disease 27 April 2017
FDA takes action against 14 companies for selling illegal cancer treatments 25 April 2017
FDA approves first drug to treat tardive dyskinesia 12 April 2017
FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions 06 April 2017
FDA approves new eczema drug Dupixent 28 March 2017
FDA approves first treatment for rare form of skin cancer 24 March 2017
FDA approves drug to treat Parkinson's disease 22 March 2017
Mutual Recognition promises new framework for pharmaceutical inspections for United States and European Union 03 March 2017
FDA approves Odactra for house dust mite allergies 01 March 2017
FDA approves drug to treat Duchenne muscular dystrophy 10 February 2017
FDA approves first drug for spinal muscular atrophy 27 December 2016
FDA grants accelerated approval to new treatment for advanced ovarian cancer 20 December 2016
FDA research to help speed development of Zika virus vaccines and therapeutics 17 November 2016
FDA awards 21 grants to stimulate product development for rare diseases 17 October 2016
FDA launches #NaloxoneApp competition to spur innovative technologies to help reduce opioid overdose deaths 21 September 2016
FDA grants accelerated approval to first drug for Duchenne muscular dystrophy 19 September 2016
FDA updates warnings for fluoroquinolone antibiotics 26 July 2016
FDA approves new medication for dry eye disease 12 July 2016
FDA advances Precision Medicine Initiative by issuing draft guidances on next generation sequencing-based tests 08 July 2016
FDA targets unlawful internet sales of illegal prescription medicines during International Operation Pangea IX 10 June 2016
  • Start
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next
  • End

Business & Industry

  • CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
  • AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge

Research & Development

  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer
  • Engineered bacteria find tumors, then alert the authorities
  • First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. FDA

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.